Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for Pain and Inflammation Management
Introduction to Nabumetone
- Nabumetone has demonstrated a more favorable GI safety profile compared to many traditional NSAIDs, with a lower incidence of peptic ulcers, perforations, and bleeding, according to the American Gastroenterological Association 1
Cardiovascular Risks
- All NSAIDs, including nabumetone, may increase the risk of cardiovascular events, and should be used with caution in patients with cardiovascular disease, as recommended by the American Heart Association 2
- Data from Kaiser Permanente showed an increased risk of thromboembolic events with nabumetone, similar to other NSAIDs like indomethacin and naproxen, highlighting the need for careful patient selection and monitoring 1
Prescribing Considerations
- When prescribing nabumetone, evaluate gastrointestinal, renal, and cardiovascular status before initiating therapy, and monitor for signs of GI bleeding, especially in high-risk patients, as suggested by the European League Against Rheumatism 3
- Use the lowest effective dose for the shortest duration possible to minimize risks, as recommended by the American College of Cardiology 2
- Consider gastroprotective agents, such as proton pump inhibitors (PPIs), in high-risk patients to reduce the risk of GI complications, according to the American Gastroenterological Association 4
Dosage and Administration
- Standard dosing for nabumetone is 1-2g once daily, typically at bedtime, with dosage adjustment may be needed in elderly patients, those with active rheumatic disease, or hepatic impairment 1